Citius Pharmaceuticals launches cancer drug LYMPHIR following FDA approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. PATH
5. DOCU
6. ASAN
7. SPY
8. CIEN
9. GWRE
10. CPB

Go back to Citius Pharmaceuticals launches cancer drug LYMPHIR following FDA approval
(NASDAQ: CTOR) Delayed: 0.79 --0 (-0%)
Previous Close $0.79    52 Week High $ 
Open $0.79    52 Week Low $ 
Day High $0.79    P/E N/A 
Day Low $0.79    EPS $ 
Volume 150       

(NASDAQ: CTXR) Delayed: 0.60 --0 (-0%)
Previous Close $0.60    52 Week High $2.50 
Open $0.60    52 Week Low $0.40 
Day High $0.60    P/E N/A 
Day Low $0.60    EPS $0.00 
Volume 21